Himension Capital Singapore PTE. LTD. Purchases 24,633 Shares of UnitedHealth Group Incorporated $UNH

Himension Capital Singapore PTE. LTD. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 384.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 31,041 shares of the healthcare conglomerate’s stock after buying an additional 24,633 shares during the period. UnitedHealth Group makes up about 0.8% of Himension Capital Singapore PTE. LTD.’s investment portfolio, making the stock its 17th largest holding. Himension Capital Singapore PTE. LTD.’s holdings in UnitedHealth Group were worth $9,684,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Caitlin John LLC grew its position in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Murphy Pohlad Asset Management LLC increased its position in UnitedHealth Group by 21.8% during the second quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock valued at $1,380,000 after acquiring an additional 791 shares during the last quarter. Triumph Capital Management purchased a new position in UnitedHealth Group in the second quarter worth about $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares during the last quarter. Finally, Towercrest Capital Management bought a new stake in UnitedHealth Group during the second quarter valued at approximately $236,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $326.23 on Wednesday. The firm’s fifty day moving average is $343.84 and its two-hundred day moving average is $315.01. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The company has a market cap of $295.51 billion, a P/E ratio of 17.03, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter last year, the firm earned $7.15 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Mizuho upped their price target on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Jefferies Financial Group boosted their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Barclays increased their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.